StealAt this price, it's a steal. I am surprised not alot of people are realizing that. This company has one of a kind voucher that accelerated the FDA process from 10 to 6 months. The thing is that Ebola classifies as a tropical disease as well so you will see big name companies bidding for this. Huge market potential. Company is also run by a smart man. Johnathan Goodman, same guy who took his previous company from $4/share to $150 before selling it for $3BILLION.